Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03534323 |
Title | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Dana-Farber Cancer Institute |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Miami- Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | United States | Details | |
Northern Light Eastern Maine Medical Center | Brewer | Maine | 04412 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Boston Medical Center | Boston | Massachusetts | 02118 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Berkshire Medical Center | Pittsfield | Massachusetts | 01201 | United States | Details |